Literature DB >> 6979471

Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis.

J Powell-Tuck, D W Day, N A Buckell, J Wadsworth, J E Lennard-Jones.   

Abstract

It has been widely assumed that the activity of ulcerative colitis is related to differences in mucosal appearances seen at sigmoidoscopic examination. We have tested this assumption by making comparisons of the symptoms and clinical signs associated with three reproducible appearances of the rectal mucosa. By cross-tabulating 222 observations of each of 10 symptoms and signs with these sigmoidoscopic appearances it has been shown that the subdivision of hemorrhagic mucosae into those which bleed spontaneously and those which bleed only on light touching or scraping is meaningful clinically. Sigmoidoscopic appearances seemed to correlate better with clinical disease activity than histological assessment, even when quantitative, of mucosal biopsies. On the basis of this study, four variables have been suggested which, in addition to the sigmoidoscopic appearances, could form the basis of regular clinical assessment or scoring.

Entities:  

Mesh:

Year:  1982        PMID: 6979471     DOI: 10.1007/BF01296733

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.

Authors:  N A Buckell; S R Gould; D W Day; J E Lennard-Jones; A M Edwards
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

2.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

3.  VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.

Authors:  J H BARON; A M CONNELL; J E LENNARD-JONES
Journal:  Br Med J       Date:  1964-01-11

4.  Ulcerative colitis. A follow-up investigation with mucosal biopsy studies.

Authors:  A P DICK; M J GRAYSON
Journal:  Br Med J       Date:  1961-01-21

5.  Biopsy studies in ulcerative colitis.

Authors:  S C TRUELOVE; W C RICHARDS
Journal:  Br Med J       Date:  1956-06-09

6.  Sigmoidoscopy and cytology in the detection of microscopic disease of the rectal mucosa in ulcerative colitis.

Authors:  J M Watts; H Thompson; J C Goligher
Journal:  Gut       Date:  1966-06       Impact factor: 23.059

7.  The value of rectal biopsy in the diagnosis of ulcerative colitis.

Authors:  S G MATTS
Journal:  Q J Med       Date:  1961-10

8.  A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis.

Authors:  V Binder
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

9.  Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets.

Authors:  R Wright; S R Truelove
Journal:  Am J Dig Dis       Date:  1966-11

10.  A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis.

Authors:  J Powell-Tuck; R L Bown; J E Lennard-Jones
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

  10 in total
  47 in total

1.  Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study.

Authors:  D Ludwig; S Wiener; A Brüning; K Schwarting; G Jantschek; K Fellermann; M Stahl; E F Stange
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

Review 2.  Assessing disease activity and disease activity indices for inflammatory bowel disease.

Authors:  Feng Xiao Li; Lloyd R Sutherland
Journal:  Curr Gastroenterol Rep       Date:  2002-12

Review 3.  Mucosal healing in inflammatory bowel disease: where do we stand?

Authors:  Christina Ha; Asher Kornbluth
Journal:  Curr Gastroenterol Rep       Date:  2010-12

4.  Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis.

Authors:  Y Nishio; T Ando; O Maeda; K Ishiguro; O Watanabe; N Ohmiya; Y Niwa; K Kusugami; H Goto
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

5.  Morphometric studies in rectal biopsy specimens from patients with ulcerative colitis: effect of oral 5 amino salicylic acid and rectal prednisolone treatment.

Authors:  A M Zaitoun; I Cobden; H al Mardini; C O Record
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

6.  Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation.

Authors:  Tetsuji Kudo; Takayuki Matsumoto; Motohiro Esaki; Takashi Yao; Mitsuo Iida
Journal:  Int J Colorectal Dis       Date:  2009-01-15       Impact factor: 2.571

7.  Prognostic indicators and clinical course in proctosigmoiditis.

Authors:  L D Juby; D E Long; M F Dixon; A T Axon
Journal:  Int J Colorectal Dis       Date:  1990-12       Impact factor: 2.571

8.  Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity.

Authors:  J Broekroelofs; A H Mulder; G F Nelis; B D Westerveld; J W Tervaert; C G Kallenberg
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

9.  Disease characteristics of inflammatory bowel disease (IBD): findings from a tertiary care centre in South Asia.

Authors:  Duminda Subasinghe; N M M Nawarathna; Dharmabandhu Nandadeva Samarasekera
Journal:  J Gastrointest Surg       Date:  2011-06-28       Impact factor: 3.452

10.  Colonic bicarbonate output as a test of disease activity in ulcerative colitis.

Authors:  W E Roediger; M J Lawson; V Kwok; A K Grant; P R Pannall
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.